SAM
Silvercrest Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,603
| Closed | -$331K | – | 804 |
|
|
2024
Q2 | $331K | Sell |
1,603
-6,513
| -80% | -$1.35M | ﹤0.01% | 799 |
|
|
2024
Q1 | $2.2M | Buy |
8,116
+912
| +13% | +$247K | 0.01% | 501 |
|
|
2023
Q4 | $1.7M | Buy |
7,204
+436
| +6% | +$103K | 0.01% | 518 |
|
|
2023
Q3 | $1.33M | Buy |
6,768
+439
| +7% | +$86K | 0.01% | 547 |
|
|
2023
Q2 | $1.33M | Buy |
6,329
+1,123
| +22% | +$236K | 0.01% | 541 |
|
|
2023
Q1 | $1.05M | Buy |
5,206
+164
| +3% | +$33.1K | 0.01% | 573 |
|
|
2022
Q4 | $1.1M | Sell |
5,042
-244
| -5% | -$53.2K | 0.01% | 563 |
|
|
2022
Q3 | $1.04M | Buy |
+5,286
| New | +$1.04M | 0.01% | 548 |
|
|
2022
Q1 | – | Sell |
-590
| Closed | -$222K | – | 856 |
|
|
2021
Q4 | $222K | Sell |
590
-50
| -8% | -$18.8K | ﹤0.01% | 785 |
|
|
2021
Q3 | $264K | Hold |
640
| – | – | ﹤0.01% | 773 |
|
|
2021
Q2 | $237K | Buy |
+640
| New | +$237K | ﹤0.01% | 785 |
|